Autologous mesenchymal stem cells for the results of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis
The therapeutic potential of mesenchymal stem cell transplantation as a results for multiple sclerosis: consensus report of the International MSCT Study Group
Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months
